Schonfeld Strategic Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $556K | Sell |
15,445
-31,107
| -67% | -$1.12M | ﹤0.01% | 1428 |
|
|
2025
Q1 | $1.45M | Sell |
46,552
-32,590
| -41% | -$1.01M | 0.01% | 1017 |
|
|
2024
Q4 | $2.02M | Buy |
79,142
+34,537
| +77% | +$881K | 0.01% | 771 |
|
|
2024
Q3 | $1.26M | Buy |
44,605
+30,528
| +217% | +$864K | 0.01% | 951 |
|
|
2024
Q2 | $371K | Buy |
14,077
+3,065
| +28% | +$80.8K | ﹤0.01% | 1465 |
|
|
2024
Q1 | $334K | Sell |
11,012
-5,582
| -34% | -$170K | ﹤0.01% | 1422 |
|
|
2023
Q4 | $466K | Buy |
16,594
+5,757
| +53% | +$162K | ﹤0.01% | 1229 |
|
|
2023
Q3 | $294K | Sell |
10,837
-238,640
| -96% | -$6.48M | ﹤0.01% | 1198 |
|
|
2023
Q2 | $7.67M | Buy |
249,477
+198,462
| +389% | +$6.1M | 0.07% | 404 |
|
|
2023
Q1 | $1.84M | Sell |
51,015
-162,222
| -76% | -$5.84M | 0.02% | 709 |
|
|
2022
Q4 | $8.43M | Buy |
213,237
+191,437
| +878% | +$7.57M | 0.07% | 345 |
|
|
2022
Q3 | $876K | Sell |
21,800
-4,167
| -16% | -$167K | 0.01% | 1337 |
|
|
2022
Q2 | $1.09M | Sell |
25,967
-50,287
| -66% | -$2.11M | 0.01% | 914 |
|
|
2022
Q1 | $2.97M | Buy |
76,254
+14,964
| +24% | +$583K | 0.03% | 554 |
|
|
2021
Q4 | $2.44M | Buy |
+61,290
| New | +$2.44M | 0.02% | 601 |
|
|
2021
Q3 | – | Sell |
-8,843
| Closed | -$362K | – | 2262 |
|
|
2021
Q2 | $362K | Sell |
8,843
-97,237
| -92% | -$3.98M | ﹤0.01% | 1313 |
|
|
2021
Q1 | $4.63M | Buy |
106,080
+81,080
| +324% | +$3.54M | 0.06% | 415 |
|
|
2020
Q4 | $1.25M | Sell |
25,000
-7,418
| -23% | -$371K | 0.02% | 701 |
|
|
2020
Q3 | $1.36M | Buy |
+32,418
| New | +$1.36M | 0.03% | 582 |
|